Skip to main content

Table 1 Pf TrxR inhibitory and antiplasmodial activities of tested compounds

From: Characterization of PfTrxR inhibitors using antimalarial assays and in silicotechniques

Test compounds

PfTrxR IC50(μM)*

Pf(D6) CQ sensitive IC50(μM)**

SI D6

Pf(W2) CQ resistance IC50(μM)**

SI W2

3T3 IC50(μM)

1,4-NQ

0.75

8.9 ± 2.3

4.6

16.7 ± 3.7

2.4

38.5 ± 0.76

2,4-DNPS

0.5

91.2 ± 11.3

0.8

72.3 ± 11.3

1.0

79 ± 3.51

4-NBT

2

8.3 ± 2.1

10

9.8 ± 1.9

8

80 ± 1.15

3-DAP

15.4

>100

>1

>100

>1

>100

MD

1.6

18.5 ± 1.9

3.8

28.3 ± 5.6

2.5

70.5 ± 3.69

CQ

 

0.055 ± 0.006

 

0.440 ± 0.045

 

NC

  1. *IC50 values, preparation of PfTrxR and optimal experimental conditions for the PfTrxR functional assay were reported in Andricopulo et al., 2006 [12]; Charvet et al., 2003 [13]; Munigunti et al., 2012 [14].
  2. **Values are mean ± S.D. of triplicate observations; SI: Selectivity index. NC: no cytotoxicity up to concentration much higher than the concentration responsible for its antiplasmodial activity.